» Articles » PMID: 4392560

Local Anaesthetic and Anti-arrhythmic Actions of Alprenolol Relative to Its Effect on Intracellular Potentials and Other Properties of Isolated Cardiac Muscle

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1970 Apr 1
PMID 4392560
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

1. Alprenolol, a beta-adrenoceptor blocking drug reported to have the same potency as propranolol in vitro and in vivo, was found to be four times more active than procaine as a local anaesthetic on frog sciatic nerve.2. At doses of 0.125 mg/kg and above alprenolol protected anaesthetized guinea-pigs against ouabain-induced ventricular fibrillation.3. In isolated rabbit atria, resting potentials were unchanged, and the duration of the action potential was not prolonged, by concentrations of alprenolol up to 10.5 x 10(-6)M. The maximum rate of depolarization (MRD), however, was reduced by 30% at a concentration of 0.525 x 10(-6)M. This was 214 times less than the concentration which reduced the frog action potential height by 25%.4. The concentration of alprenolol required to produce more than 15% decrease in contraction or maximum driven frequency was 3.5 x 10(-6)M.5. As a test of the direct action of alprenolol on isolated cardiac muscle, MRD was also a more sensitive test than the measurement of electrical threshold or conduction velocity.

Citing Articles

Antiarrhythmic drug research.

Walker M Br J Pharmacol. 2006; 147 Suppl 1:S222-31.

PMID: 16402108 PMC: 1760742. DOI: 10.1038/sj.bjp.0706500.


The role of the local anaesthetic properties of beta-adrenoceptor blocking agents in antagonizing CaCl2-induced arrhythmias in the rat.

Evangelista S, Maggi C, Meli A Br J Pharmacol. 1981; 73(3):725-7.

PMID: 6113866 PMC: 2071696. DOI: 10.1111/j.1476-5381.1981.tb16808.x.


Inhibition of lymphocyte capping and transformation by propranolol and related compounds.

Anderton B, Axford J, COHN P, Marshall N, Shen L, Sprake S Br J Pharmacol. 1981; 72(1):69-74.

PMID: 6112036 PMC: 2071544. DOI: 10.1111/j.1476-5381.1981.tb09106.x.


A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474.

Singh B, VAUGHAN WILLIAMS E Br J Pharmacol. 1970; 39(4):675-87.

PMID: 5485144 PMC: 1702723. DOI: 10.1111/j.1476-5381.1970.tb09893.x.


Atrial repolarization in man. Effect of beta-receptor blockade.

Olsson S Br Heart J. 1974; 36(8):806-10.

PMID: 4412123 PMC: 458898. DOI: 10.1136/hrt.36.8.806.


References
1.
Noble D, Tsien R . Outward membrane currents activated in the plateau range of potentials in cardiac Purkinje fibres. J Physiol. 1969; 200(1):205-31. PMC: 1350425. DOI: 10.1113/jphysiol.1969.sp008689. View

2.
Ablad B, Brogard M, Ek L . Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist. Acta Pharmacol Toxicol (Copenh). 1967; 25:9-40. View

3.
McAllister R, Noble D . The effect of subthreshold potentials on the membrane current in cardiac Purkinje fibres. J Physiol. 1967; 190(2):381-7. PMC: 1365301. DOI: 10.1113/jphysiol.1967.sp008216. View

4.
Williams E, Sekiya A . Prevention of arrhythmias due to cardiac glycosides by block of sympathetic beta receptors. Lancet. 1963; 1(7278):420-1. DOI: 10.1016/s0140-6736(63)92306-7. View

5.
Dudel J, Peper K, Rudel R, TRAUTWEIN W . Effect of tetrodotoxin on membrane currents in mammalian cardiac fibres. Nature. 1967; 213(5073):296-7. DOI: 10.1038/213296a0. View